Sotera Health Company (SHC) News
Follow Sotera Health Company (SHC) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 13 public stories across 5 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Sotera Health Reports 2026 Revenue of $324.89M and Net Income of $58.39M
Revenue rose 4.4% year over year to $324.89 million, while net income increased 20.6% to $58.39 million. Diluted EPS was $0.20, compared with $0.17 in the prior-year period.
EARNINGS | Nov 03, 2026, 09:11 PM UTC
M
Sotera Health Reports Quarterly Results for Period Ended September 30
Sotera Health Company reported results for the quarter ended September 30; no figures were provided.
EQUITY | Nov 03, 2026, 02:32 PM UTC
M
Sotera Health Reports Higher Q3 Adjusted Earnings and Revenue, Updates 2026 Guidance
Sotera Health reported higher third-quarter adjusted earnings and revenue and updated its 2026 revenue guidance. The supplied report does not include figures or the guidance details.
EQUITY | Nov 03, 2026, 01:19 PM UTC
M
Sotera Health Sets FY Adjusted EPS Outlook
EARNINGS | Nov 03, 2026, 12:32 PM UTC
M
Sotera Health Expects 2026 Revenue of $1.23B to $1.25B
Sotera Health expects 2026 revenue of $1.23B to $1.25B, versus a FactSet estimate of $1.25B.
EARNINGS | Nov 03, 2026, 12:32 PM UTC
M
Sotera Health Q3 Revenue Beats Estimates on Pricing and Volume
EQUITY | Nov 03, 2026, 12:20 PM UTC
M
Sotera Health Reports Q3 2026 Revenue Growth of 4.4%
Q3 2026 net revenues increased 4.4% on both an as-reported and constant-currency basis.
EQUITY | Nov 03, 2026, 12:03 PM UTC
H
Transcript: Sotera Health Q2 2026 Earnings Conference Call
Sotera Health (NASDAQ: SHC ) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. APIs provide real-time access to earnings call transcripts and financial data. Vi
LIVE | Oct 09, 2026, 09:12 AM UTC
L
SHC: Integrated growth, capacity expansion, and strong cash flow drive a resilient outlook
The business is driving growth through integrated sterilization and lab services, robust investments in capacity and supply security, and disciplined capital allocation. Margin expansion and strong free cash flow are exp
EARNINGS | Sep 09, 2026, 07:28 PM UTC
L
SHC: Integrated healthcare services, robust growth, and strategic investments drive future expansion
The company operates three synergistic business units critical to healthcare, with strong Q2 growth in both Sterigenics and Nelson Labs. Strategic investments in capacity, regulatory compliance, and Cobalt-60 supply unde
EQUITY | Sep 09, 2026, 06:42 PM UTC
L
Sotera Health Raises FY2026 Adj EPS Guidance from $0.93-$1.01 to $0.95-$1.01 vs $0.97 Est; Raises FY2026 Sales Guidance from $1.233B-$1.251B
Sotera Health (NASDAQ: SHC ) raises FY2026 Adj EPS guidance from $0.93-$1.01 to $0.95-$1.01 vs $0.97 analyst estimate. Raises FY2026 sales outlook from $1.233 billion-$1.251 billion to $1.236 billion-$1.254 billion vs $1
EARNINGS | Aug 06, 2026, 11:03 AM UTC
L
SHC - Sotera Health Delivers Strong Second-Quarter and First-Half 2026 Results and Raises FY 2026 Outlook
SHC - Sotera Health Delivers Strong Second-Quarter and First-Half 2026 Results and Raises FY 2026 Outlook
EQUITY | Aug 06, 2026, 11:00 AM UTC
M
SHC: Barclays Raises PT
Barclays maintains overweight rating on Sotera Health and raises price target to $19
EQUITY | Jun 24, 2026, 02:55 PM UTC